25 XP   0   0   10

ViroGates A/S
Buy, Hold or Sell?

Let's analyse Virogates together

PenkeI guess you are interested in ViroGates A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ViroGates A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ViroGates A/S

I send you an email if I find something interesting about ViroGates A/S.

Quick analysis of Virogates (30 sec.)










What can you expect buying and holding a share of Virogates? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr1.13
Expected worth in 1 year
kr-0.50
How sure are you?
13.6%

+ What do you gain per year?

Total Gains per Share
kr-1.64
Return On Investment
-25.2%

For what price can you sell your share?

Current Price per Share
kr6.50
Expected price per share
kr4.98 - kr7.3
How sure are you?
50%

1. Valuation of Virogates (5 min.)




Live pricePrice per Share (EOD)

kr6.50

Intrinsic Value Per Share

kr-24.35 - kr-28.23

Total Value Per Share

kr-23.22 - kr-27.10

2. Growth of Virogates (5 min.)




Is Virogates growing?

Current yearPrevious yearGrowGrow %
How rich?$1m$2.1m-$482.5k-29.0%

How much money is Virogates making?

Current yearPrevious yearGrowGrow %
Making money-$382.8k-$430.9k$48k12.6%
Net Profit Margin-151.6%-124.3%--

How much money comes from the company's main activities?

3. Financial Health of Virogates (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#301 / 340

Most Revenue
#286 / 340

Most Profit
#132 / 340

Most Efficient
#262 / 340

What can you expect buying and holding a share of Virogates? (5 min.)

Welcome investor! Virogates's management wants to use your money to grow the business. In return you get a share of Virogates.

What can you expect buying and holding a share of Virogates?

First you should know what it really means to hold a share of Virogates. And how you can make/lose money.

Speculation

The Price per Share of Virogates is kr6.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Virogates.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Virogates, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr1.13. Based on the TTM, the Book Value Change Per Share is kr-0.41 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Virogates.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.05-0.7%-0.06-0.9%-0.07-1.0%-0.09-1.3%-0.09-1.4%
Usd Book Value Change Per Share-0.05-0.7%-0.06-0.9%-0.01-0.2%-0.06-1.0%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-0.7%-0.06-0.9%-0.01-0.2%-0.06-1.0%0.010.1%
Usd Price Per Share3.05-4.66-12.87-10.70-10.80-
Price to Earnings Ratio-15.90--21.70--46.64--31.49--31.72-
Price-to-Total Gains Ratio-63.63--86.81--161.17--123.56--121.34-
Price to Book Ratio18.52-17.91-39.41-22.12-20.83-
Price-to-Total Gains Ratio-63.63--86.81--161.17--123.56--121.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9425
Number of shares1061
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.06-0.06
Usd Total Gains Per Share-0.06-0.06
Gains per Quarter (1061 shares)-63.03-68.40
Gains per Year (1061 shares)-252.12-273.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-252-2620-274-284
20-504-5140-547-558
30-756-7660-821-832
40-1008-10180-1094-1106
50-1261-12700-1368-1380
60-1513-15220-1642-1654
70-1765-17740-1915-1928
80-2017-20260-2189-2202
90-2269-22780-2463-2476
100-2521-25300-2736-2750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.022.00.00.0%0.022.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%3.019.00.013.6%3.019.00.013.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.022.00.0%0.00.022.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%3.019.00.013.6%3.019.00.013.6%

Fundamentals of Virogates

About ViroGates A/S

ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and suPARnostic ELISA that provides fully quantitative results. Its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was incorporated in 2000 and is headquartered in Birkerød, Denmark.

Fundamental data was last updated by Penke on 2024-03-12 10:44:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ViroGates A/S.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Virogates earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Virogates to the Medical Devices industry mean.
  • A Net Profit Margin of -81.3% means that kr-0.81 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ViroGates A/S:

  • The MRQ is -81.3%. The company is making a huge loss. -2
  • The TTM is -151.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-81.3%TTM-151.6%+70.3%
TTM-151.6%YOY-124.3%-27.3%
TTM-151.6%5Y-378.9%+227.3%
5Y-378.9%10Y-393.7%+14.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-81.3%-10.6%-70.7%
TTM-151.6%-20.2%-131.4%
YOY-124.3%-14.0%-110.3%
5Y-378.9%-19.5%-359.4%
10Y-393.7%-23.8%-369.9%
1.1.2. Return on Assets

Shows how efficient Virogates is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Virogates to the Medical Devices industry mean.
  • -14.6% Return on Assets means that Virogates generated kr-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ViroGates A/S:

  • The MRQ is -14.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.6%TTM-17.2%+2.6%
TTM-17.2%YOY-16.6%-0.6%
TTM-17.2%5Y-13.7%-3.5%
5Y-13.7%10Y-13.2%-0.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.6%-3.0%-11.6%
TTM-17.2%-4.2%-13.0%
YOY-16.6%-4.0%-12.6%
5Y-13.7%-3.8%-9.9%
10Y-13.2%-4.1%-9.1%
1.1.3. Return on Equity

Shows how efficient Virogates is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Virogates to the Medical Devices industry mean.
  • -29.1% Return on Equity means Virogates generated kr-0.29 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ViroGates A/S:

  • The MRQ is -29.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.1%TTM-25.5%-3.6%
TTM-25.5%YOY-20.0%-5.5%
TTM-25.5%5Y-16.8%-8.6%
5Y-16.8%10Y-16.1%-0.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.1%-3.5%-25.6%
TTM-25.5%-4.4%-21.1%
YOY-20.0%-4.7%-15.3%
5Y-16.8%-5.7%-11.1%
10Y-16.1%-6.2%-9.9%

1.2. Operating Efficiency of ViroGates A/S.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Virogates is operating .

  • Measures how much profit Virogates makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Virogates to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ViroGates A/S:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-6.4%+6.4%
TTM-6.4%YOY-139.0%+132.6%
TTM-6.4%5Y-386.4%+379.9%
5Y-386.4%10Y-384.1%-2.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.5%+24.5%
TTM-6.4%-14.9%+8.5%
YOY-139.0%-11.5%-127.5%
5Y-386.4%-17.1%-369.3%
10Y-384.1%-20.6%-363.5%
1.2.2. Operating Ratio

Measures how efficient Virogates is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.01 means that the operating costs are kr2.01 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of ViroGates A/S:

  • The MRQ is 2.006. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.789. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.006TTM2.789-0.783
TTM2.789YOY2.643+0.146
TTM2.7895Y5.919-3.130
5Y5.91910Y6.077-0.158
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0061.454+0.552
TTM2.7891.452+1.337
YOY2.6431.434+1.209
5Y5.9191.432+4.487
10Y6.0771.366+4.711

1.3. Liquidity of ViroGates A/S.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Virogates is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.39 means the company has kr7.39 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of ViroGates A/S:

  • The MRQ is 7.392. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.782. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.392TTM11.782-4.390
TTM11.782YOY6.792+4.990
TTM11.7825Y11.477+0.304
5Y11.47710Y11.699-0.222
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3922.789+4.603
TTM11.7822.793+8.989
YOY6.7923.586+3.206
5Y11.4773.492+7.985
10Y11.6993.450+8.249
1.3.2. Quick Ratio

Measures if Virogates is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Virogates to the Medical Devices industry mean.
  • A Quick Ratio of 0.63 means the company can pay off kr0.63 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ViroGates A/S:

  • The MRQ is 0.632. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.353. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.632TTM1.353-0.721
TTM1.353YOY1.777-0.424
TTM1.3535Y1.036+0.317
5Y1.03610Y1.022+0.014
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6321.587-0.955
TTM1.3531.633-0.280
YOY1.7772.185-0.408
5Y1.0362.300-1.264
10Y1.0222.255-1.233

1.4. Solvency of ViroGates A/S.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Virogates assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Virogates to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.50 means that Virogates assets are financed with 49.8% credit (debt) and the remaining percentage (100% - 49.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ViroGates A/S:

  • The MRQ is 0.498. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.264. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.498TTM0.264+0.234
TTM0.264YOY0.161+0.103
TTM0.2645Y0.141+0.123
5Y0.14110Y0.136+0.005
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4980.400+0.098
TTM0.2640.386-0.122
YOY0.1610.330-0.169
5Y0.1410.440-0.299
10Y0.1360.460-0.324
1.4.2. Debt to Equity Ratio

Measures if Virogates is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Virogates to the Medical Devices industry mean.
  • A Debt to Equity ratio of 99.1% means that company has kr0.99 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ViroGates A/S:

  • The MRQ is 0.991. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.460. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.991TTM0.460+0.531
TTM0.460YOY0.196+0.264
TTM0.4605Y0.195+0.265
5Y0.19510Y0.186+0.009
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9910.566+0.425
TTM0.4600.569-0.109
YOY0.1960.479-0.283
5Y0.1950.626-0.431
10Y0.1860.692-0.506

2. Market Valuation of ViroGates A/S

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Virogates generates.

  • Above 15 is considered overpriced but always compare Virogates to the Medical Devices industry mean.
  • A PE ratio of -15.90 means the investor is paying kr-15.90 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ViroGates A/S:

  • The EOD is -4.922. Based on the earnings, the company is expensive. -2
  • The MRQ is -15.900. Based on the earnings, the company is expensive. -2
  • The TTM is -21.705. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.922MRQ-15.900+10.979
MRQ-15.900TTM-21.705+5.804
TTM-21.705YOY-46.638+24.933
TTM-21.7055Y-31.494+9.789
5Y-31.49410Y-31.719+0.225
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.922-1.038-3.884
MRQ-15.900-1.216-14.684
TTM-21.705-1.757-19.948
YOY-46.638-2.582-44.056
5Y-31.494-1.553-29.941
10Y-31.719-1.463-30.256
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ViroGates A/S:

  • The EOD is -4.915. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.878. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -24.652. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.915MRQ-15.878+10.963
MRQ-15.878TTM-24.652+8.774
TTM-24.652YOY-43.138+18.485
TTM-24.6525Y-28.266+3.613
5Y-28.26610Y-25.696-2.570
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.915-1.207-3.708
MRQ-15.878-1.746-14.132
TTM-24.652-2.961-21.691
YOY-43.138-6.143-36.995
5Y-28.266-4.928-23.338
10Y-25.696-5.626-20.070
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Virogates is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 18.52 means the investor is paying kr18.52 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of ViroGates A/S:

  • The EOD is 5.732. Based on the equity, the company is overpriced. -1
  • The MRQ is 18.520. Based on the equity, the company is expensive. -2
  • The TTM is 17.907. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.732MRQ18.520-12.788
MRQ18.520TTM17.907+0.613
TTM17.907YOY39.409-21.502
TTM17.9075Y22.119-4.212
5Y22.11910Y20.834+1.285
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.7322.038+3.694
MRQ18.5202.321+16.199
TTM17.9072.444+15.463
YOY39.4093.028+36.381
5Y22.1193.918+18.201
10Y20.8344.245+16.589
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ViroGates A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.330-0.410+24%-0.100-70%-0.445+35%0.052-740%
Book Value Per Share--1.1341.783-36%2.300-51%4.520-75%5.037-77%
Current Ratio--7.39211.782-37%6.792+9%11.477-36%11.699-37%
Debt To Asset Ratio--0.4980.264+89%0.161+210%0.141+252%0.136+265%
Debt To Equity Ratio--0.9910.460+115%0.196+406%0.195+408%0.186+433%
Dividend Per Share----0%-0%-0%-0%
Eps---0.330-0.410+24%-0.461+40%-0.602+82%-0.625+89%
Free Cash Flow Per Share---0.331-0.390+18%-0.605+83%-0.623+88%-0.623+88%
Free Cash Flow To Equity Per Share---0.331-0.390+18%0.839-139%-0.004-99%-0.004-99%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---28.231--------
Intrinsic Value_10Y_min---24.355--------
Intrinsic Value_1Y_max---2.580--------
Intrinsic Value_1Y_min---2.534--------
Intrinsic Value_3Y_max---7.942--------
Intrinsic Value_3Y_min---7.578--------
Intrinsic Value_5Y_max---13.533--------
Intrinsic Value_5Y_min---12.544--------
Market Cap41892305.000-223%135344370.000207205785.500-35%571829963.250-76%475635563.515-72%480176630.786-72%
Net Profit Margin---0.813-1.516+86%-1.243+53%-3.789+366%-3.937+384%
Operating Margin----0.0640%-1.3900%-3.8640%-3.8410%
Operating Ratio--2.0062.789-28%2.643-24%5.919-66%6.077-67%
Pb Ratio5.732-223%18.52017.907+3%39.409-53%22.119-16%20.834-11%
Pe Ratio-4.922+69%-15.900-21.705+37%-46.638+193%-31.494+98%-31.719+99%
Price Per Share6.500-223%21.00032.150-35%88.725-76%73.800-72%74.504-72%
Price To Free Cash Flow Ratio-4.915+69%-15.878-24.652+55%-43.138+172%-28.266+78%-25.696+62%
Price To Total Gains Ratio-19.695+69%-63.632-86.813+36%-161.168+153%-123.556+94%-121.337+91%
Quick Ratio--0.6321.353-53%1.777-64%1.036-39%1.022-38%
Return On Assets---0.146-0.172+18%-0.166+14%-0.137-6%-0.132-10%
Return On Equity---0.291-0.255-13%-0.200-31%-0.168-42%-0.161-45%
Total Gains Per Share---0.330-0.410+24%-0.100-70%-0.445+35%0.052-740%
Usd Book Value--1059660.0001666702.500-36%2149226.250-51%4224309.889-75%4707517.273-77%
Usd Book Value Change Per Share---0.048-0.059+24%-0.015-70%-0.064+35%0.007-740%
Usd Book Value Per Share--0.1640.259-36%0.333-51%0.655-75%0.730-77%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.048-0.059+24%-0.067+40%-0.087+82%-0.091+89%
Usd Free Cash Flow---308995.000-364638.750+18%-565717.500+83%-436486.250+41%-396805.682+28%
Usd Free Cash Flow Per Share---0.048-0.057+18%-0.088+83%-0.090+88%-0.090+88%
Usd Free Cash Flow To Equity Per Share---0.048-0.057+18%0.122-139%-0.001-99%-0.001-99%
Usd Market Cap6074384.225-223%19624933.65030044838.898-35%82915344.671-76%68967156.710-72%69625611.464-72%
Usd Price Per Share0.943-223%3.0454.662-35%12.865-76%10.701-72%10.803-72%
Usd Profit---308560.000-382872.500+24%-430940.000+40%-559928.962+81%-581957.322+89%
Usd Revenue--379465.000457765.000-17%379718.7500%274979.479+38%262610.568+44%
Usd Total Gains Per Share---0.048-0.059+24%-0.015-70%-0.064+35%0.007-740%
 EOD+3 -5MRQTTM+17 -15YOY+13 -195Y+16 -1610Y+12 -20

3.2. Fundamental Score

Let's check the fundamental score of ViroGates A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.922
Price to Book Ratio (EOD)Between0-15.732
Net Profit Margin (MRQ)Greater than0-0.813
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.632
Current Ratio (MRQ)Greater than17.392
Debt to Asset Ratio (MRQ)Less than10.498
Debt to Equity Ratio (MRQ)Less than10.991
Return on Equity (MRQ)Greater than0.15-0.291
Return on Assets (MRQ)Greater than0.05-0.146
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of ViroGates A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.381
Ma 20Greater thanMa 507.410
Ma 50Greater thanMa 1007.782
Ma 100Greater thanMa 2008.025
OpenGreater thanClose6.600
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in DKK. All numbers in thousands.

Summary
Total Assets14,552
Total Liabilities7,244
Total Stockholder Equity7,308
 As reported
Total Liabilities 7,244
Total Stockholder Equity+ 7,308
Total Assets = 14,552

Assets

Total Assets14,552
Total Current Assets14,377
Long-term Assets176
Total Current Assets
Cash And Cash Equivalents 6,420
Net Receivables 1,230
Inventory 4,055
Other Current Assets 1
Total Current Assets  (as reported)14,377
Total Current Assets  (calculated)11,706
+/- 2,671
Long-term Assets
Property Plant Equipment 6
Long-term Assets  (as reported)176
Long-term Assets  (calculated)6
+/- 170

Liabilities & Shareholders' Equity

Total Current Liabilities1,945
Long-term Liabilities5,299
Total Stockholder Equity7,308
Total Current Liabilities
Accounts payable 923
Other Current Liabilities 1,022
Total Current Liabilities  (as reported)1,945
Total Current Liabilities  (calculated)1,945
+/-0
Long-term Liabilities
Long term Debt 5,300
Long-term Liabilities Other -1
Long-term Liabilities  (as reported)5,299
Long-term Liabilities  (calculated)5,299
+/-0
Total Stockholder Equity
Retained Earnings 3,957
Total Stockholder Equity (as reported)7,308
Total Stockholder Equity (calculated)3,957
+/- 3,351
Other
Capital Stock3,351
Common Stock Shares Outstanding 4,342
Net Invested Capital 12,608
Net Working Capital 12,432
Property Plant and Equipment Gross 14



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
75,754
68,146
63,423
60,135
56,410
52,466
45,157
39,246
43,697
43,021
38,246
29,677
27,958
23,298
20,229
17,485
13,167
19,871
17,539
14,114
15,906
14,552
14,55215,90614,11417,53919,87113,16717,48520,22923,29827,95829,67738,24643,02143,69739,24645,15752,46656,41060,13563,42368,14675,754
   > Total Current Assets 
75,465
67,887
63,196
59,936
56,075
51,930
44,442
38,585
43,087
42,355
37,643
29,132
27,465
22,858
19,838
17,147
12,881
19,638
17,310
13,921
15,721
14,377
14,37715,72113,92117,31019,63812,88117,14719,83822,85827,46529,13237,64342,35543,08738,58544,44251,93056,07559,93663,19667,88775,465
       Cash And Cash Equivalents 
70,533
62,590
60,083
55,992
50,165
47,625
41,407
35,724
39,431
38,028
33,526
23,562
21,323
17,475
14,859
10,870
4,636
11,173
9,878
6,462
8,551
6,420
6,4208,5516,4629,87811,1734,63610,87014,85917,47521,32323,56233,52638,02839,43135,72441,40747,62550,16555,99260,08362,59070,533
       Net Receivables 
4,103
4,559
2,385
752
809
129
2,294
1,787
2,850
3,513
3,161
3,662
3,746
3,283
3,244
4,171
5,198
4,081
3,625
1,641
688
1,230
1,2306881,6413,6254,0815,1984,1713,2443,2833,7463,6623,1613,5132,8501,7872,2941298097522,3854,5594,103
       Inventory 
566
567
694
578
829
741
390
249
488
586
907
1,494
2,099
1,801
1,695
1,922
2,491
4,242
3,770
3,596
4,137
4,055
4,0554,1373,5963,7704,2422,4911,9221,6951,8012,0991,494907586488249390741829578694567566
   > Long-term Assets 
0
0
0
198
334
536
715
661
608
666
603
545
492
440
391
339
286
233
229
193
184
176
176184193229233286339391440492545603666608661715536334198000
       Property Plant Equipment 
180
149
117
86
55
257
548
494
494
495
432
373
321
268
216
163
110
58
40
23
14
6
6142340581101632162683213734324954944945482575586117149180
       Long-term Assets Other 
0
0
0
198
334
536
715
661
0
0
0
0
-1
0
-1
0
0
-1
0
0
0
0
0000-100-10-10000661715536334198000
> Total Liabilities 
8,794
3,526
2,412
2,798
3,423
3,474
2,942
3,219
4,193
7,265
6,932
2,639
3,190
2,850
3,803
4,025
1,634
2,001
1,451
967
6,471
7,244
7,2446,4719671,4512,0011,6344,0253,8032,8503,1902,6396,9327,2654,1933,2192,9423,4743,4232,7982,4123,5268,794
   > Total Current Liabilities 
8,794
3,526
2,412
2,798
3,423
3,474
2,942
3,219
4,192
7,265
6,932
2,638
3,190
2,850
3,803
4,025
1,634
2,002
1,451
968
1,171
1,945
1,9451,1719681,4512,0021,6344,0253,8032,8503,1902,6386,9327,2654,1923,2192,9423,4743,4232,7982,4123,5268,794
       Accounts payable 
4,367
722
339
1,108
1,343
1,385
927
1,242
1,276
1,022
3,654
785
1,484
1,012
380
3,300
310
1,408
574
490
393
923
9233934905741,4083103,3003801,0121,4847853,6541,0221,2761,2429271,3851,3431,1083397224,367
       Other Current Liabilities 
4,216
2,804
2,073
1,690
2,081
2,089
2,015
1,977
2,916
6,243
3,278
1,853
1,706
1,838
3,423
725
1,324
594
877
478
778
1,022
1,0227784788775941,3247253,4231,8381,7061,8533,2786,2432,9161,9772,0152,0892,0811,6902,0732,8044,216
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
-1
0
-1
5,300
5,299
5,2995,300-10-100000100100000000
       Other Liabilities 
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000100000000
> Total Stockholder Equity
66,961
64,620
61,011
57,336
52,987
48,993
42,215
36,027
39,504
35,756
31,314
27,038
24,768
20,448
16,426
13,460
11,533
17,870
16,088
13,147
9,435
7,308
7,3089,43513,14716,08817,87011,53313,46016,42620,44824,76827,03831,31435,75639,50436,02742,21548,99352,98757,33661,01164,62066,961
   Common Stock
3,034
3,034
3,034
3,034
3,034
3,034
3,034
3,034
3,125
3,125
3,125
3,125
3,170
3,170
3,170
3,170
3,170
3,351
3,350
0
0
0
0003,3503,3513,1703,1703,1703,1703,1703,1253,1253,1253,1253,0343,0343,0343,0343,0343,0343,0343,034
   Retained Earnings 
63,926
61,585
57,977
54,302
49,952
45,958
39,181
32,993
36,379
32,631
28,189
23,913
21,598
17,278
13,256
10,290
8,363
14,519
12,738
9,796
6,084
3,957
3,9576,0849,79612,73814,5198,36310,29013,25617,27821,59823,91328,18932,63136,37932,99339,18145,95849,95254,30257,97761,58563,926
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
-1
0
0
0
0
0000-100000100000000000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,460
Cost of Revenue-1,575
Gross Profit7,8857,885
 
Operating Income (+$)
Gross Profit7,885
Operating Expense-20,719
Operating Income-11,259-12,834
 
Operating Expense (+$)
Research Development7,207
Selling General Administrative11,937
Selling And Marketing Expenses-
Operating Expense20,71919,144
 
Net Interest Income (+$)
Interest Income46
Interest Expense-409
Other Finance Cost-0
Net Interest Income-363
 
Pretax Income (+$)
Operating Income-11,259
Net Interest Income-363
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-11,623-11,259
EBIT - interestExpense = -409
-10,562
-10,153
Interest Expense409
Earnings Before Interest and Taxes (EBIT)--11,214
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-11,623
Tax Provision--1,061
Net Income From Continuing Ops-10,562-10,562
Net Income-10,562
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-363
 

Technical Analysis of Virogates
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Virogates. The general trend of Virogates is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Virogates's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ViroGates A/S.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.74 < 7.12 < 7.3.

The bearish price targets are: 5.68 > 5.26 > 4.98.

Tweet this
ViroGates A/S Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ViroGates A/S. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ViroGates A/S Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ViroGates A/S. The current macd is -0.32341673.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Virogates price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Virogates. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Virogates price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ViroGates A/S Daily Moving Average Convergence/Divergence (MACD) ChartViroGates A/S Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ViroGates A/S. The current adx is 21.93.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Virogates shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
ViroGates A/S Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ViroGates A/S. The current sar is 7.63131788.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ViroGates A/S Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ViroGates A/S. The current rsi is 35.38. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
ViroGates A/S Daily Relative Strength Index (RSI) ChartViroGates A/S Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ViroGates A/S. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Virogates price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ViroGates A/S Daily Stochastic Oscillator ChartViroGates A/S Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ViroGates A/S. The current cci is -198.39802834.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ViroGates A/S Daily Commodity Channel Index (CCI) ChartViroGates A/S Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ViroGates A/S. The current cmo is -41.64006957.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ViroGates A/S Daily Chande Momentum Oscillator (CMO) ChartViroGates A/S Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ViroGates A/S. The current willr is -62.87878788.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Virogates is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ViroGates A/S Daily Williams %R ChartViroGates A/S Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ViroGates A/S.

ViroGates A/S Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ViroGates A/S. The current atr is 0.55915828.

ViroGates A/S Daily Average True Range (ATR) ChartViroGates A/S Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ViroGates A/S. The current obv is -411,144.

ViroGates A/S Daily On-Balance Volume (OBV) ChartViroGates A/S Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ViroGates A/S. The current mfi is 8.9599002.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
ViroGates A/S Daily Money Flow Index (MFI) ChartViroGates A/S Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ViroGates A/S.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

ViroGates A/S Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ViroGates A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.381
Ma 20Greater thanMa 507.410
Ma 50Greater thanMa 1007.782
Ma 100Greater thanMa 2008.025
OpenGreater thanClose6.600
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Virogates with someone you think should read this too:
  • Are you bullish or bearish on Virogates? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Virogates? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ViroGates A/S

I send you an email if I find something interesting about ViroGates A/S.


Comments

How you think about this?

Leave a comment

Stay informed about ViroGates A/S.

Receive notifications about ViroGates A/S in your mailbox!